Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood
Journal of Thrombosis and Haemostasis,
Journal Year:
2023,
Volume and Issue:
21(9), P. 2313 - 2326
Published: June 1, 2023
Language: Английский
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID‐19
Adam Paul Yan,
No information about this author
Chase Parsons,
No information about this author
Gregory H. Caplan
No information about this author
et al.
Pediatric Blood & Cancer,
Journal Year:
2024,
Volume and Issue:
71(3)
Published: Jan. 3, 2024
Abstract
Objective
To
design
and
evaluate
a
clinical
decision
support
(CDS)
module
to
improve
guideline
concordant
venous
thromboembolism
(VTE)
pharmacoprophylaxis
prescribing
for
pediatric
inpatients
with
COVID‐19.
Materials
methods
The
proportion
of
patients
who
met
our
institutional
practice
guideline's
(CPG)
criteria
VTE
prophylaxis
was
compared
those
triggered
CDS
alert,
indicating
the
patient
needed
prophylaxis,
were
prescribed
pre
post
launch
new
prescribing.
sensitivity,
specificity,
positive
predictive
value
(PPV),
negative
value,
F1‐score
accuracy
tool
calculated
pre‐
post‐intervention
periods
using
CPG
recommendation
as
gold
standard.
Accuracy
defined
sum
true
positives
negatives
over
positives,
false
negatives,
negatives.
Logistic
regression
used
identify
variables
associated
correct
thromboprophylaxis
Results
A
significant
increase
in
triggering
alert
occurred
period
(44.3%
vs.
6.9%,
p
<
.001);
however,
no
reciprocal
achieved
(36.6%
40.9%,
=
.53).
updated
had
an
improved
sensitivity
(55.0%
13.3%),
NPV
(44.9%
36.3%),
(66.7%
23.5%),
(62.5%
42.0%),
but
inferior
specificity
(78.6%
100%)
PPV
(84.6%
100%).
Discussion
model
overall
performance
correctly
identifying
requiring
prophylaxis.
Despite
identification
by
module,
receiving
appropriate
pharmacologic
did
not
change.
Conclusion
tools
need
ongoing
refinement
validation
maximize
utility.
Language: Английский
Age and sex-specific stroke epidemiology in COVID-19
Frontiers in Stroke,
Journal Year:
2023,
Volume and Issue:
2
Published: June 7, 2023
Background
COVID-19
has
emerged
as
an
independent
risk
factor
for
stroke.
We
aimed
to
determine
age
and
sex-specific
stroke
incidence
factors
with
in
the
US
using
a
large
electronic
health
record
(EHR)
that
included
both
inpatients
outpatients.
Methods
A
retrospective
cohort
study
was
conducted
individual-level
data
from
Optum
®
de-identified
EHR.
total
of
387,330
individuals
aged
≥
18
laboratory-confirmed
between
March
1,
2020
December
31,
were
included.
The
primary
outcome
cumulative
after
confirmation
within
180
days
follow-up
or
until
death.
Kaplan–Meier
curves
acute
ischemic
(AIS),
intracerebral
hemorrhage
(ICH),
composite
all
strokes
stratified
by
sex
age,
differences
assessed
log-rank
test.
relative
demographics
estimated
multivariable
Cox-proportional
hazards
regressions
adjusted
hazard
ratios
(aHRs).
Results
Of
patients,
2,752
patients
(0.71%,
95%
CI
0.68–0.74)
developed
during
180-day
follow-up,
AIS
0.65%
(95%
0.62–0.67),
ICH
0.11%
0.10–0.12).
among
57%
occurred
3
days.
Advanced
associated
substantially
higher
risk,
aHR
6.92
(5.72–8.38)
ages
65–74,
9.42
(7.74–11.47)
75–84,
11.35
(9.20–14.00)
85
older
compared
18–44
years.
Men
had
32%
women.
African-American
[aHR
1.78
(1.61–1.97)]
Hispanic
1.48
(1.30–1.69)]
increased
white
patients.
Conclusion
This
several
important
findings.
is
highest
first
positivity;
this
decreases
time.
(both
inpatient
outpatient)
follow-up.
Traditional
increase
COVID-19.
Male
across
groups.
have
Language: Английский
COVID‐19 Infection Is Associated With Poor Outcomes in Patients With Intracerebral Hemorrhage
Journal of the American Heart Association,
Journal Year:
2024,
Volume and Issue:
13(3)
Published: Jan. 31, 2024
Patients
with
ischemic
stroke
and
concomitant
COVID-19
infection
have
worse
outcomes
than
those
without
this
infection,
but
the
impact
of
on
hemorrhagic
remains
unclear.
We
aimed
to
assess
if
worsens
in
intracerebral
hemorrhage
(ICH).
Language: Английский
Postrecovery COVID-19 and interlinking diabetes and cardiovascular events
Elsevier eBooks,
Journal Year:
2024,
Volume and Issue:
unknown, P. 377 - 382
Published: Jan. 1, 2024
Language: Английский
Stroke risks in patients with COVID-19: multiple mechanisms of SARS-CoV-2, impact of sex and age, vaccination, and long-term infection
Moawiah M. Naffaa,
No information about this author
Ola A. Al-Ewaidat
No information about this author
Deleted Journal,
Journal Year:
2024,
Volume and Issue:
1(1)
Published: Sept. 20, 2024
Language: Английский
Trends in the Diagnosis of Pediatric Venous Thromboembolism and Arterial Ischemic Stroke during the COVID-19 Pandemic: An Administrative Database Study
Riten Kumar,
No information about this author
Nan Chen,
No information about this author
Laura L. Lehman
No information about this author
et al.
The Journal of Pediatrics,
Journal Year:
2024,
Volume and Issue:
unknown, P. 114328 - 114328
Published: Sept. 1, 2024
Language: Английский
COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation
American Journal of Cardiovascular Drugs,
Journal Year:
2024,
Volume and Issue:
24(5), P. 693 - 702
Published: Aug. 13, 2024
Language: Английский
Association between SARS-CoV-2 Seropositivity and Severity of Out-of-Hospital Acute Ischemic Stroke Following Asymptomatic/Mild COVID-19 in Children
Journal of Pediatric Infectious Diseases,
Journal Year:
2023,
Volume and Issue:
19(01), P. 028 - 038
Published: Dec. 11, 2023
Abstract
Objective
This
article
investigates
the
frequency
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
seropositivity
and
its
association
with
severity
new-onset
ischemic
stroke
(AIS)
among
previously
healthy
children
asymptomatic/mild
disease
2019
(COVID-19).
Methods
A
case–control
study
that
included
<
18
years
out-of-hospital
AIS
undetermined
etiology
a
control
group
children.
Exclusion
criteria
were
current
symptoms,
previous
COVID-19
diagnosis,
prior
vaccination,
active
SARS-CoV-2
infection,
history
hospital
admission
in
last
6
months,
having
predisposition.
We
screened
for
immunoglobulin
G
antibodies
using
enzyme-linked
immunosorbent
assay.
The
was
evaluated
Pediatric
National
Institutes
Health
Stroke
Scale
(PedNIHSS).
Results
25
(15
males
10
females;
median
age
24
months)
controls
(11
14
months).
detected
15
(60%)
11
(44%)
(p
=
0.258).
Compared
seronegative
children,
those
seropositive
had
higher
PedNIHSS
scores
(median
19
vs.
8.5;
p
0.001),
pediatric
intensive
care
unit
(93.3%
40%;
0.007),
need
mechanical
ventilation
(53.3%
10%;
0.040),
D-dimer
levels
3.5
1.75
μg/mL;
0.001).
Conclusion
may
be
associated
more
affecting
during
postacute
phase
asymptomatic/mildly
symptomatic
COVID-19.
Language: Английский